Literature DB >> 19621659

Clinical course and indications for steroid therapy of sclerosing cholangitis associated with autoimmune pancreatitis.

Takahiro Nakazawa1, Hirotaka Ohara, Tomoaki Ando, Kazuki Hayashi, Itaru Naitoh, Fumihiro Okumura, Hajime Tanaka, Hitoshi Sano, Takashi Joh.   

Abstract

BACKGROUND/AIMS: There have been only a few reports about the clinical course and indications for steroid therapy of autoimmune pancreatitis (AIP). We studied 45 cases of AIP to clarify the clinical course and indications for steroid therapy, from the viewpoint of associated sclerosing cholangitis (SC).
METHODOLOGY: Two groups (with and without progression or recurrence) were compared by cholangiographic classification, blood chemistry, initial therapy, presenting symptoms and pancreatic findings.
RESULTS: One patient with AIP and no stricture and seven patients with AIP and SC with stricture of the lower common bile duct showed strictures of the intrahepatic bile duct and hilar hepatic lesions during their clinical course. SC patients with intrahepatic stenosis showed higher IgG levels than those with stenosis of the lower common bile duct only. Six of seven cases without steroid therapy and IgG >2000 mg/dL showed significantly greater recurrence or progression of SC.
CONCLUSIONS: When a patient with SC and AIP with elevated levels of IgG (>2000 mg/dL) is encountered, steroid administration should be initiated immediately.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19621659

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation.

Authors:  Itaru Naitoh; Yoh Zen; Takahiro Nakazawa; Tomoaki Ando; Kazuki Hayashi; Fumihiro Okumura; Katsuyuki Miyabe; Michihiro Yoshida; Shunsuke Nojiri; Takayoshi Kanematsu; Hirotaka Ohara; Takashi Joh
Journal:  J Gastroenterol       Date:  2010-09-07       Impact factor: 7.527

Review 2.  Diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Simizu; Takashi Joh
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

3.  Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.

Authors:  Masaki Miyazawa; Hajime Takatori; Tetsuro Shimakami; Kazunori Kawaguchi; Kazuya Kitamura; Kuniaki Arai; Koichiro Matsuda; Taku Sanada; Takeshi Urabe; Katsuhisa Inamura; Takashi Kagaya; Hideki Mizuno; Uichiro Fuchizaki; Taro Yamashita; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Masao Honda; Shuichi Kaneko
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.